John O Agwunobi
CIK 1627893 · Chairman and CEO · last filed 2026-07-22
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$3.34M
Companies
5
Total Filings
56
Lifetime Open-Market Net
$312.4K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ENSG | Director | 9,503 | $180.20 | $1.71M | -$262.2K | 20 | 2026-07-22 |
| bluebird bio, Inc. (BLUE) Delisted | Director | 1,245 | $4.97 | $6.2K | $0 | 10 | 2025-06-03 |
| HLF | Chairman and CEO | 134,745 | $11.74 | $1.58M | $574.5K | 16 | 2022-05-11 |
| NKTR | Director | 618 | $75.50 | $46.7K | $0 | 3 | 2018-05-25 |
| MAGELLAN HEALTH INC (MGLN) Delisted | Director | 3,150 | $94.99 | $299.2K | $0 | 2 | 2015-05-22 |
Recent Filings · Page 5 of 6
56 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-02-23 | HLF | Mixed | +21,873 | -$67.9K | EDGAR |
| 2021-02-10 | HLF | Mixed | +20,908 | -$955.3K | EDGAR |
| 2020-06-22 | bluebird bio, Inc. (BLUE) Delisted | Grant (A) | +1,624 | $0 | EDGAR |
| 2020-04-01 | HLF | Grant (A) | +19,217 | $0 | EDGAR |
| 2020-02-28 | HLF | Tax (F) | −513 | -$17.1K | EDGAR |
| 2020-02-24 | HLF | Mixed | +7,992 | -$17.3K | EDGAR |
| 2019-06-10 | bluebird bio, Inc. (BLUE) Delisted | Grant (A) | +1,000 | $0 | EDGAR |
| 2019-02-28 | HLF | Tax (F) | −538 | -$30.4K | EDGAR |
| 2019-02-25 | HLF | Grant (A) | +5,701 | $0 | EDGAR |
| 2018-06-22 | bluebird bio, Inc. (BLUE) Delisted | Grant (A) | +1,000 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.